BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24612219)

  • 1. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
    Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
    Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    PLoS One; 2017; 12(10):e0185636. PubMed ID: 28968424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
    Liu Q; Lv GD; Qin X; Gen YH; Zheng ST; Liu T; Lu XM
    Mol Biol Rep; 2012 Feb; 39(2):1239-46. PubMed ID: 21598109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
    Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
    Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
    Chang CJ; Hsu CC; Chang CH; Tsai LL; Chang YC; Lu SW; Yu CH; Huang HS; Wang JJ; Tsai CH; Chou MY; Yu CC; Hu FW
    Oncol Rep; 2011 Oct; 26(4):1003-10. PubMed ID: 21725603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
    Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
    Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
    Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
    BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
    Liu DK; Yu S; Li JP; Song WW; Li JH
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
    Jin L; Yi J; Gao Y; Han S; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):810-9. PubMed ID: 27563011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
    Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
    Zhu M; Zhang C; Chen D; Chen S; Zheng H
    Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and significance of miR-33b and HMGA2 in esophageal squamous cell carcinoma].
    Jin L; Jin J; Lu W; Yao J; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1238-42. PubMed ID: 27609581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
    Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
    J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.